Elanco Animal Health (NYSE:ELAN) 2025 Earnings Call Presentation
2025-12-09 14:00
Defining Elanco's New Era of Growth December 9, 2025 1 Introduction Tiffany Kanaga VP Investor Relations & ESG 2 Notices and Disclaimers Forward-Looking Statements. This presentation contains forward-looking statements within the meaning of the federal securities laws, including, without limitation, statements concerning product launches and revenue from such products, our 2025 full year and fourth quarter guidance, long-term expectations, our expectations regarding debt levels, and expectations regarding o ...
The Andersons (NasdaqGS:ANDE) 2025 Earnings Call Presentation
2025-12-09 14:00
Investor Day December 9, 2025 New York City 2025 INVESTOR DAY Welcome and Opening Remarks Mike Hoelter VP, CORPORATE CONTROLLER AND INVESTOR RELATIONS 2025 INVESTOR DAY W E S E R V E 2 Safe Harbor and Non-GAAP Financial Measures Certain information disclosed constitutes forward-looking statements. Actual results could differ materially from those presented in the forward-looking statements as a result of many factors including general economic, weather, and regulatory conditions, competition, geopolitical r ...
KeyCorp (NYSE:KEY) Earnings Call Presentation
2025-12-09 13:40
KeyCorp Goldman Sachs 2025 U.S. Financial Services Conference December 9, 2025 Chris Gorman Chairman and Chief Executive Officer Forward-looking Statements and Additional Information This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including, but not limited to, KeyCorp's expectations or predictions of future financial or business performance or conditions. Forward-looking statements are typically identified by words such as "b ...
SailPoint Inc(SAIL) - 2026 Q3 - Earnings Call Presentation
2025-12-09 13:30
Fiscal Q3'26 Earnings Presentation December 9, 2025 Important notice and disclaimers Forward-Looking Statements This presentation of SailPoint, Inc. (the "Company" or "SailPoint") contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical fact included in this presentation are forward-looking statements. Forward-looking statements give the Company's current expectations and projections relating to its financial condition, results of op ...
Ferguson plc(FERG) - 2026 Q1 - Earnings Call Presentation
2025-12-09 13:30
Quarter Ended October 31, 2025 Results Presentation Legal Disclaimer Cautionary note on forward-looking statements Certain information included in this presentation and discussed on the conference call that this presentation accompanies is forward-looking, including within the meaning of the Private Securities Litigation Reform Act of 1995, and involves risks, assumptions and uncertainties that could cause actual results to differ materially from those expressed or implied by forward-looking statements. For ...
The Home Depot (NYSE:HD) 2025 Earnings Call Presentation
2025-12-09 13:30
TED DECKER CHAIR, PRESIDENT & CEO 2025 INVESTOR AND ANALYST CONFERENCE 1 Winning Formula MASSIVE MARKET OPPORUNITY CULTURE AND VALUES DISTINCT COMPETITIVE ADVANTAGES STRATEGY ~$1.1T TOTAL ADDRESSABLE MARKET $900B+ REMAINING OPPORTUNITY BRAND SCALE PREMIER REAL ESTATE ASSOCIATES & CULTURE SUPPLY CHAIN DIGITAL & INTERCONNECTED PRODUCT AUTHORITY PRO DELIVER A FRICTIONLESS INTERCONNECTED EXPERIENCE WIN THE PRO DRIVE OUR CORE AND CULTURE 2 Large and Highly Fragmented Market TOTAL ADDRESSABLE MARKET MARKET SHARE ...
nyte Software .(CGNT) - 2026 Q3 - Earnings Call Presentation
2025-12-09 13:30
December 9, 2025 © 2025 Cognyte Ltd. All Rights Reserved. Proprietary & Confidential Disclaimers Forward Looking Statements This presentation contains "forward-looking statements," including statements regarding expectations, predictions, views, opportunities, plans, strategies, beliefs, and statements of similar effect relating to Cognyte Software Ltd. These forward-looking statements are not guarantees of future performance and they are based on management's expectations that involve a number of known and ...
AT&T (NYSE:T) 2025 Earnings Call Presentation
2025-12-09 13:15
John Stankey Chairman of the Board and Chief Executive Officer AT&T Inc. December 9, 2025 UBS Global Media and Communications Conference 2025 © 2025 AT&T Intellectual Property. AT&T and globe logo are registered trademarks and service marks of Cautionary Language Concerning Forward-looking Statements Information set forth in this presentation contains financial estimates and other forward-looking statements that are subject to risks and uncertainties, and actual results might differ materially. A discussion ...
TopBuild (NYSE:BLD) 2025 Earnings Call Presentation
2025-12-09 13:00
Company Overview and Strategy - TopBuild has a market capitalization of approximately $12.5 billion and operates over 450 branches [21] - The company's sales breakdown is 56% from Installation Services and 44% from Specialty Distribution [21] - TopBuild's strategy focuses on operational excellence, talent development, technology leverage, and strategic M&A [24] - Since 2022, TopBuild has expanded its total addressable market by approximately 6x to over $90 billion [26] Financial Performance and Outlook - TopBuild's 2025 proforma TTM sales for Installation Services are $3.527 billion, with an adjusted EBITDA of $761.552 million [314] - Specialty Distribution's 2025 proforma TTM sales are $3.101 billion, with an adjusted EBITDA of $485.763 million [314] - The company is committed to delivering $35 million to $40 million in synergies from the SPI acquisition over the next two years [181] - TopBuild anticipates 2030 sales of $9 billion to $10 billion, with a cumulative free cash flow between 2026 and 2030 of $4.2 billion to $5.0 billion [302] M&A Activity - Since 2022, TopBuild has completed 24 acquisitions, contributing over $1.5 billion in revenue [33] - The company has deployed $2.2 billion in capital for M&A since 2022 [33] - M&A remains TopBuild's number one capital allocation priority [286]
Senti Biosciences (NasdaqCM:SNTI) Earnings Call Presentation
2025-12-09 13:00
SENTI-202-101 Promising Results in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) in Ongoing Phase 1 Trial (SENTI-202-101) December 9, 2025 Conference Call and Webcast NASDAQ: SNTI | sentibio.com Forward Looking Statements This presentation contains forward-looking statements of Senti Biosciences, Inc. ("we," "us," "our") within the meaning of the Private Securities Litigation Reform Act of 1995. Statements we make in this presentation may include statements which are not historical f ...